Decoding Tumor Complexity

Decoding Tumor Complexity

An Integrative Framework Linking Chromatin Topology to Therapeutic Resistance

by Peter Oloche David

Browse books you can read free on Readfeed

No club is reading this yet — be the first to start one

Start a club free
About
Tumor heterogeneity poses a formidable challenge in oncology, manifesting as genetic, epigenetic, and phenotypic variations within neoplastic tissues that underpin therapeutic resistance and metastatic progression. This abstract delineates an integrative framework leveraging spatial transcriptomics and 3D chromatin conformation capture to unravel and mitigate intratumoral diversity. The primary objective is to dissect the spatiotemporal dynamics of genomic architecture in solid tumors, hypothesizing that aberrant chromatin looping and spatial gene expression patterns drive subclonal evolution. Employing high-resolution spatial RNA sequencing (e.g., Visium platform) alongside Hi-C and derivative techniques, we mapped 3D genomic interactions across patient-derived tumor organoids and biopsy samples from breast and colorectal carcinomas (n=45).

Discuss Decoding Tumor Complexity with other readers

Join or start a book club for Decoding Tumor Complexity on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Frequently asked questions

How do I join a book club for Decoding Tumor Complexity?

Sign up free on Readfeed, then browse public clubs or start your own club with Decoding Tumor Complexity as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Decoding Tumor Complexity with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Decoding Tumor Complexity with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.